Kleeblattschaedel

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Kleeblattschaedel | |
|---|---|
| File:Child with extreme congenital proptosis and microcephalus Wellcome L0062479.jpg | |
| Synonyms | Cloverleaf skull |
| Pronounce | N/A |
| Specialty | Neurosurgery, Pediatrics |
| Symptoms | Craniosynostosis, proptosis, hydrocephalus |
| Complications | Developmental delay, neurological impairment |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutations, fibroblast growth factor receptor mutations |
| Risks | Genetic predisposition |
| Diagnosis | Clinical examination, imaging studies |
| Differential diagnosis | Crouzon syndrome, Apert syndrome |
| Prevention | N/A |
| Treatment | Surgical intervention, cranial vault remodeling |
| Medication | N/A |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |


Kleeblattsch√§del Syndrome (also known as Cloverleaf Skull Syndrome) is a rare congenital disorder characterized by a complex craniosynostosis that results in a cloverleaf-shaped skull. This condition is associated with a fusion of multiple skull bones, which affects the shape of the head and face. Kleeblattsch√§del Syndrome is a part of a group of disorders known as craniosynostosis syndromes, which involve premature fusion of one or more of the cranial sutures.
Etiology[edit]
The exact cause of Kleeblattsch√§del Syndrome is not fully understood, but it is believed to be related to genetic mutations. It has been associated with mutations in several genes, including the FGFR2 (Fibroblast Growth Factor Receptor 2) and TWIST1 genes. These mutations are thought to affect the development of the skull bones during embryonic development.
Symptoms[edit]
The most notable symptom of Kleeblattsch√§del Syndrome is the cloverleaf-shaped skull. Other symptoms can include:
- Hydrocephalus (accumulation of fluid in the brain)
- Proptosis (bulging of the eyes)
- Midface hypoplasia (underdevelopment of the middle facial structures)
- Intellectual disability
- Respiratory problems
- Hearing loss
Diagnosis[edit]
Diagnosis of Kleeblattsch√§del Syndrome is primarily based on physical examination and imaging studies, such as X-rays and MRI (Magnetic Resonance Imaging). These imaging techniques can help in assessing the extent of craniosynostosis and other associated abnormalities.
Treatment[edit]
Treatment of Kleeblattsch√§del Syndrome is complex and often requires a multidisciplinary approach. Surgical intervention is typically necessary to correct the shape of the skull and alleviate increased intracranial pressure. Multiple surgeries may be required as the child grows. Management also includes treatment of associated conditions, such as hydrocephalus, which may require the placement of a ventriculoperitoneal shunt.
Prognosis[edit]
The prognosis for individuals with Kleeblattsch√§del Syndrome varies depending on the severity of the condition and the presence of associated anomalies. Early and aggressive treatment can improve outcomes, but the condition can be life-threatening, especially in severe cases.
Epidemiology[edit]
Kleeblattsch√§del Syndrome is extremely rare, with only a small number of cases reported in the medical literature. It affects males and females equally.
NIH genetic and rare disease info[edit]
Kleeblattschaedel is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Kleeblattschaedel
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian